中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 国家授时中心
  3. 中国科学院国家授时中心
热门
Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study

文献类型：期刊论文

作者Wang, Yuan6; Feng, Lan-lan5; Ji, Pei-gang6; Liu, Jing-hui6; Guo, Shao-chun6; Zhai, Yu-long6; Sankey, Eric W.4; Wang, Yue3; Xue, Yan-rong1,2; Wang, Na6
刊名FRONTIERS IN ONCOLOGY
出版日期2021-02-15
卷号10页码:10
关键词diffuse midline glioma radiotherapy P53 KPS
ISSN号2234-943X
DOI10.3389/fonc.2020.602553
英文摘要Purpose Diffuse midline gliomas (DMG) with H3K27M mutations have been identified as a rare distinctive entity with unique genetic features, varied molecular alterations, and poor prognosis. The current study aimed to evaluate the clinical characteristics and profile of molecular markers on patients with a DMG harboring H3K27M mutations, and explore the impact of this genetic makeup on overall survival. Methods We retrospectively analyzed 43 consecutive patients diagnosed with a DMG harboring H3K27M mutations (age range 3 to 75 years) and treated in a tertiary institution within China between January 2017 to December 2019. Various clinical and molecular factors were evaluated to assess their prognostic value in this unique patient cohort. Results The median overall survival (OS) was 12.83 months. Preoperative Karnofsky Performance Score (KPS) and adjuvant radiotherapy were found to be independent clinical parameters influencing the OS by multivariate analysis (p = 0.027 and p < 0.001 respectively). Whereas extent of tumor resection failed to demonstrate statistical significance. For molecular markers, P53 overexpression was identified as a negative prognostic factor for overall survival by multivariate analysis (p = 0.030). Conclusion Low preoperative KPS, absence of radiotherapy and P53 overexpression were identified as predictors of a dismal overall survival in patients with DMG and H3K27M mutations.
资助项目National Natural Science Foundation of China[81601100] ; National Natural Science Foundation of China[81772661]
WOS研究方向Oncology
语种英语
WOS记录号WOS:000623215300001
出版者FRONTIERS MEDIA SA
资助机构National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China
源URL[http://210.72.145.45/handle/361003/12142]  
专题中国科学院国家授时中心
通讯作者Qu, Yan; Gong, Li; Wang, Liang
作者单位1.Univ Chinese Acad Sci, Sch Optoelect, Beijing, Peoples R China
2.Chinese Acad Sci, Natl Time Serv Ctr, Xian, Peoples R China
3.Fourth Mil Med Univ, Dept Hlth Stat, Xian, Peoples R China
4.Duke Univ Hosp, Dept Neurosurg, Durham, NC USA
5.Fourth Mil Med Univ, Tangdu Hosp, Dept Pathol, Xian, Peoples R China
6.Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China
推荐引用方式
GB/T 7714		 Wang, Yuan,Feng, Lan-lan,Ji, Pei-gang,et al. Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study[J]. FRONTIERS IN ONCOLOGY,2021,10:10.
APA Wang, Yuan.,Feng, Lan-lan.,Ji, Pei-gang.,Liu, Jing-hui.,Guo, Shao-chun.,...&Wang, Liang.(2021).Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study.FRONTIERS IN ONCOLOGY,10,10.
MLA Wang, Yuan,et al."Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study".FRONTIERS IN ONCOLOGY 10(2021):10.

入库方式： OAI收割

来源：国家授时中心

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。